Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals 2024-07-11 08:21
Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut 2024-07-10 23:00
3D Artificial Cornea from Stem Cells: Chula Researchers Advance Canine Corneal Wound Treatment 2024-07-10 09:00
MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions 2024-07-08 17:14
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics 2024-07-08 14:30
Olverembatinib Approved for Commercialization in Macau China 2024-07-08 08:55
XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country 2024-07-05 21:18
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition 2024-07-05 19:00
Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Ascentage Pharma Received US$100 Million Option Payment from Takeda 2024-07-04 08:28
/C O R R E C T I O N -- Menarini Silicon Biosystems/ 2024-07-03 03:24
PolyU study reveals the mechanism of bio-inspired control of liquid flow, enlightening breakthroughs in fluid dynamics and nature-inspired materials technologies 2024-07-02 20:25
Angel Yeast Partners with ffit8 to Launch Nougat Protein Bar and Protein Nougat Snack 2024-07-02 20:00
Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease 2024-07-02 19:10
HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US 2024-07-02 10:00
Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2024-07-02 08:00
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board 2024-07-02 07:00
HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board 2024-07-01 20:00
SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors 2024-07-01 10:56
Hasten Announces Acquisition of 14 Celltrion Legacy Products, Accelerating its Business Expansion in the Pan-Asia Area 2024-06-28 16:26
1 10 11 12 13 14 229